Logo image of SLNH

SOLUNA HOLDINGS INC (SLNH) Stock Fundamental Analysis

NASDAQ:SLNH - US5835433013 - Common Stock

0.476 USD
-0.02 (-4.34%)
Last: 8/27/2025, 8:18:06 PM
0.49 USD
+0.01 (+2.94%)
After Hours: 8/27/2025, 8:18:06 PM
Fundamental Rating

1

Taking everything into account, SLNH scores 1 out of 10 in our fundamental rating. SLNH was compared to 282 industry peers in the Software industry. Both the profitability and financial health of SLNH have multiple concerns. SLNH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SLNH has reported negative net income.
In the past year SLNH has reported a negative cash flow from operations.
In the past 5 years SLNH reported 4 times negative net income.
In multiple years SLNH reported negative operating cash flow during the last 5 years.
SLNH Yearly Net Income VS EBIT VS OCF VS FCFSLNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -72.89%, SLNH is not doing good in the industry: 87.59% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -72.89%
ROE N/A
ROIC N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SLNH Yearly ROA, ROE, ROICSLNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SLNH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLNH Yearly Profit, Operating, Gross MarginsSLNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

More info and screens

0

2. Health

2.1 Basic Checks

SLNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SLNH has more shares outstanding
SLNH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SLNH has a worse debt to assets ratio.
SLNH Yearly Shares OutstandingSLNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SLNH Yearly Total Debt VS Total AssetsSLNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -5.95, we must say that SLNH is in the distress zone and has some risk of bankruptcy.
SLNH's Altman-Z score of -5.95 is on the low side compared to the rest of the industry. SLNH is outperformed by 85.11% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.95
ROIC/WACCN/A
WACC9.31%
SLNH Yearly LT Debt VS Equity VS FCFSLNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 0.33 indicates that SLNH may have some problems paying its short term obligations.
SLNH has a Current ratio of 0.33. This is amonst the worse of the industry: SLNH underperforms 93.97% of its industry peers.
SLNH has a Quick Ratio of 0.33. This is a bad value and indicates that SLNH is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.33, SLNH is doing worse than 93.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
SLNH Yearly Current Assets VS Current LiabilitesSLNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.49% over the past year.
Looking at the last year, SLNH shows a small growth in Revenue. The Revenue has grown by 2.85% in the last year.
Measured over the past years, SLNH shows a very strong growth in Revenue. The Revenue has been growing by 42.07% on average per year.
EPS 1Y (TTM)48.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.19%
Revenue 1Y (TTM)2.85%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%-52.7%

3.2 Future

SLNH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.17% yearly.
The Revenue is expected to grow by 11.57% on average over the next years. This is quite good.
EPS Next Y68.74%
EPS Next 2Y30.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.84%
Revenue Next 2Y11.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SLNH Yearly Revenue VS EstimatesSLNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
SLNH Yearly EPS VS EstimatesSLNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLNH. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SLNH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLNH Price Earnings VS Forward Price EarningsSLNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLNH Per share dataSLNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

A more expensive valuation may be justified as SLNH's earnings are expected to grow with 30.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.17%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLNH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOLUNA HOLDINGS INC

NASDAQ:SLNH (8/27/2025, 8:18:06 PM)

After market: 0.49 +0.01 (+2.94%)

0.476

-0.02 (-4.34%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-14 2025-11-14
Inst Owners8.35%
Inst Owner Change-13.96%
Ins Owners21.72%
Ins Owner Change40.94%
Market Cap16.71M
Analysts0
Price TargetN/A
Short Float %8.39%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.08
EYN/A
EPS(NY)-3.08
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.89
BVpS-0.46
TBVpS-0.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -72.89%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 80.5%
Cap/Sales 39.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -5.95
F-Score2
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)126.88%
Cap/Depr(5y)534.63%
Cap/Sales(3y)102.76%
Cap/Sales(5y)154.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.19%
EPS Next Y68.74%
EPS Next 2Y30.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.85%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%-52.7%
Revenue Next Year-5.84%
Revenue Next 2Y11.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-114.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.03%
OCF growth 3YN/A
OCF growth 5YN/A